4:23:38 AM PDT - Wednesday, August 21st, 2019

Regeneron Ebola Treatment Shows Promise, Study Stopped Early  

By Editor - Tue Aug 13, 10:17 am

Regeneron's (REGN) study on four investigational therapies for Ebola virus infection is stopped early as its therapy, REGN-EB3, was superior to Mapp Biopharmaceutical Inc.'s ZMapp in preventing death.

View original post here:

Regeneron Ebola Treatment Shows Promise, Study Stopped Early

Leave a Reply

You must sign in to post a comment.